Increased expression of METAP2 gene is associated with various forms of cancer (123), and thus methionine aminopeptidase 2 inhibitors (MetAP2) were initially developed for treatment of cancer by preventing tumour proliferation (124). This evidence concerns the gene METAP2 and neoplasm.